Musculoskeletal
1 drug is in development for Achondroplasia.
- Companies
- 1
- Clinical trials
- 19
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Achondroplasia pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| Navepegritide | Ascendis Pharma A/S (ASND) |
About this indication
Achondroplasia context
Musculoskeletal·MeSH: Achondroplasia (D000130)
Also known as: Achondroplasias
Frequently asked questions
How many drugs are in development for Achondroplasia?
BioSniper tracks 1 drug in development for Achondroplasia across 1 company.
How many clinical trials target Achondroplasia?
There are 19 clinical trials targeting Achondroplasia tracked by BioSniper.